Veeda rebrands with eye on innovator drug trials
Generic medicines-focused contract research organization Veeda Group has reorganized in a bid to add innovative drug developers, particularly in the biopharma space, to its customer base.
The Ahmedabad, India-headquartered clinical trials contractor announced the move this week, also unveiling “Veeda Lifesciences” as its new brand identity.
CEO Mahesh Bhalgat said, “The name – Veeda Lifesciences – and the new logo, designed to be modern and dynamic, symbolize the group’s forward-thinking approach and dedication to its core values and mission.
“It adds aspirational value to our growth and vision for the future, striving for innovation, excellence, and client satisfaction. We continue to diversify our base offering services serving the growing needs of our clients.”
The firm will operate four units: the core clinical trials business; a healthy volunteer services division focused on early phase trials; a biopharma services group; and a preclinical and non-clinical testing services division.
The trials business will provide services for drug trials in India and Europe, while the Gujarat-based volunteer unit will focus on the provision of clinical bioanalysis services for small molecule drug trials.
The new biopharma services operation – headquartered in Bengaluru – will provide analytical characterization and functional characterization of biologics as well as cell line and process development support.
Veeda’s rebranding is the latest stage of a business expansion effort that began in 2021 when, after receiving a $16 million private equity investment, the firm acquired Indian preclinical and non-clinical testing services-focused CRO Bioneeds.
More recently, Veeda bought Health Data Specialists – also called Heads - in a deal that gave it operational presence in 25 locations across Europe, North America, and Asia Pacific.
The expansion and prior acquisitions are in keeping with the growth plan Veeda outlined when it appointed Bhalgat as CEO in March last year.
Deposit Photos/denisismagilov